Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer
National Cancer Institute, Egypt
National Cancer Institute, Egypt
University of Maryland, Baltimore
Hospices Civils de Lyon
National Cancer Centre, Singapore
State University of Londrina
Assiut University
Eilean Therapeutics
University of Rochester
University of California, San Diego
Shanghai Junshi Bioscience Co., Ltd.
St. Justine's Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Shanghai 10th People's Hospital
Peter MacCallum Cancer Centre, Australia
Vanderbilt-Ingram Cancer Center
Centre Oscar Lambret
Jules Bordet Institute
Peking University
University of Mississippi Medical Center
M.D. Anderson Cancer Center
Fudan University
Baptist Health South Florida
Huazhong University of Science and Technology
Fudan University
UNICANCER
IntoCell, Inc
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Arizona
Insel Gruppe AG, University Hospital Bern
Icahn School of Medicine at Mount Sinai
OHSU Knight Cancer Institute
Sun Yat-sen University
Instituto de Investigacion Sanitaria La Fe
University of Iowa
I.M. Sechenov First Moscow State Medical University
University of Maryland, Baltimore
Maastricht Radiation Oncology
Zhongnan Hospital
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Second Life Therapeutics
M.D. Anderson Cancer Center
Onchilles Pharma Inc
UNICANCER
University of Chicago
University of Chicago
Immunophotonics, Inc.
The First Affiliated Hospital of Guangzhou Medical University
British Columbia Cancer Agency
InSilico Medicine Hong Kong Limited